For past so many years, the American drug industry has been making efforts to have an approved Viagra pill for women in the market. The efforts got a major boost, as a panel of the Food and Drug Administration's expert advisors have voted in the favor of the drug, called flibanserin.

Sprout Pharmaceutical has developed the drug. It was major breakthrough for the drug, as it has rejected twice since 2010. The FDA has claimed that that drug poses more risks than benefits. But the company kept on making efforts and it submitted advanced clinical data and several testimonials from women who explained how severely their personal lives have been affected due to the loss of sexual excitement.

The pill changes the levels of three chemicals in the brain, so that the sex drive of pre-menopausal women suffering loss of libido can improve. Clinical trials have shown modest increase in the drug's benefits.

Women participants who used the drug even experienced one more sexually satisfying event per month. Potential side effects include low blood pressure, dizziness and fainting in some cases.

Advocates of the campaign said that the drug has the ability to improve the lives of millions of women in America. The FDA panel has encouraged Sprout to take steps to limit the risks of the new drug and also to inform potential prescribers about the drug and its risks. Final decision with regard to the pill is expected in August.